116 related articles for article (PubMed ID: 38376277)
1. Immunolocalization of epithelial cell adhesion molecule and matrix metalloproteinase-9 in oral epithelial dysplasia and oral squamous cell carcinoma.
Maurya SB; Shetty DC; Rathore AS; Juneja S; Jain A; Banga A
J Cancer Res Ther; 2023 Oct; 19(7):1775-1780. PubMed ID: 38376277
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
3. Immunoexpression of programmed cell death 4 protein in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma.
Desai KM; Kale AD
J Oral Maxillofac Pathol; 2017; 21(3):462. PubMed ID: 29391736
[TBL] [Abstract][Full Text] [Related]
4. Expression of epithelial glycoprotein (EGP40) in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC).
Srichinthu KK; Kumar GS; Prasad H; Rajmohan M; Anuthama K; Yoithapprabhunath TR
Indian J Dent Res; 2020; 31(5):738-742. PubMed ID: 33433512
[TBL] [Abstract][Full Text] [Related]
5. Joint detection of claudin-1 and junctional adhesion molecule-A as a therapeutic target in oral epithelial dysplasia and oral squamous cell carcinoma.
Upadhaya P; Barhoi D; Giri A; Bhattacharjee A; Giri S
J Cell Biochem; 2019 Oct; 120(10):18117-18127. PubMed ID: 31161679
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Cytotoxic T Lymphocytes and Natural Killer Cell Distribution in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia: An Immunohistochemical Study.
John S; Joseph AP; Raghavan Pillai VB; Ramani P; P J; Ramalingam K
Cureus; 2024 Mar; 16(3):e56323. PubMed ID: 38628992
[TBL] [Abstract][Full Text] [Related]
7. Correlation of matrix metalloproteinase-9 expression with morphometric analysis of mucosal vasculature in oral squamous cell carcinoma, oral epithelial dysplasia, and normal oral mucosa.
Jose D; Mane DR
Int J Health Sci (Qassim); 2018; 12(6):36-43. PubMed ID: 30534042
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
9. Ki-67 Expression as a Prognostic Marker: A Comparative Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Gupta V; Ramalingam K; Yasothkumar D; Debnath D; Sundar V
Cureus; 2023 May; 15(5):e38941. PubMed ID: 37313057
[TBL] [Abstract][Full Text] [Related]
10. Anti‑EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas.
Kaneko MK; Ohishi T; Takei J; Sano M; Nakamura T; Hosono H; Yanaka M; Asano T; Sayama Y; Harada H; Kawada M; Kato Y
Oncol Rep; 2020 Dec; 44(6):2517-2526. PubMed ID: 33125138
[TBL] [Abstract][Full Text] [Related]
11. Elastin remodeling: Does it play a role in priming the malignant phenotype of oral mucosa?
Prabhudesai SA; Carvalho K; Dhupar A; Spadigam A
Indian J Pathol Microbiol; 2023; 66(2):332-338. PubMed ID: 37077077
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
Cai M; Zheng Z; Bai Z; Ouyang K; Wu Q; Xu S; Huang L; Jiang Y; Wang L; Gao J; Pathak JL; Wu L
BMC Cancer; 2022 May; 22(1):530. PubMed ID: 35545767
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of E-cadherin in oral epithelial dysplasia and squamous cell carcinoma.
Sharma J; Bhargava M; Aggarwal S; Aggarwal A; Varshney A; Chopra D
Indian J Pathol Microbiol; 2022; 65(4):755-760. PubMed ID: 36308176
[TBL] [Abstract][Full Text] [Related]
15. Immunosurveillance profile of oral squamous cell carcinoma and oral epithelial dysplasia through dendritic and T-cell analysis.
Pellicioli ACA; Bingle L; Farthing P; Lopes MA; Martins MD; Vargas PA
J Oral Pathol Med; 2017 Nov; 46(10):928-933. PubMed ID: 28585308
[TBL] [Abstract][Full Text] [Related]
16. p53 and p16 in oral epithelial dysplasia and oral squamous cell carcinoma: A study of 208 cases.
Cuevas Gonzalez JC; Gaitan Cepeda LA; Borges Yanez SA; Cornejo AD; Mori Estevez AD; Huerta ER
Indian J Pathol Microbiol; 2016; 59(2):153-8. PubMed ID: 27166031
[TBL] [Abstract][Full Text] [Related]
17. Expression of transmembrane protein aquaporin-3 in oral epithelial dysplasia and oral squamous cell carcinoma.
Lekshmy MS; Sivakumar TT; Joseph AP; Varun BR; Mony V; Reshmi A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Feb; 131(2):202-208. PubMed ID: 33187942
[TBL] [Abstract][Full Text] [Related]
18. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
[TBL] [Abstract][Full Text] [Related]
19. An Immunohistochemical Study of HIF-1 Alpha in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Patel NR; Jain L; Mahajan AM; Hiray PV; Shinde SS; Patel PA
Indian J Otolaryngol Head Neck Surg; 2019 Dec; 71(4):435-441. PubMed ID: 31750100
[TBL] [Abstract][Full Text] [Related]
20. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
Upadhyay J; Rao NN; Upadhyay RB
J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
